The central theme of the Emory Parkinson's Disease Collaborative Environmental Research Center (Emory PD-CERC) is that exposure to environmental toxicants disrupts mitochondrial function and dopamine storage, which leads to increased oxidative stress, which contributes to the pathogenesis of Parkinson's disease. The CNS program's focus on clinical research is predicated upon close interactions between clinical scientists and basic scientists. We will establish and promote these interactions at multiple levels of our administrative core. Dr. Miller is a neurotoxicologist and will serve as PI and Director of the overall program. Dr. Miller will work closely with the Co-Director Dr. DeLong. Dr. DeLong is a neurologist specializing in movement disorders. Dr. Miller and Dr. DeLong will ensure that there are rich interactions between the basic and clinical scientists involved in the program and others at the university. Emory University is internationally recognized for its pioneering translational research in Parkinson's disease. In 2002, Dr. Miller was recruited to the Center for Neurodegenerative Disease (CND) at Emory University and played an integral role in the Emory Collaborative Center for Parkinson's Disease Environmental Research or CCPDER (Dr. DeLong, P.I.). We view our application to the CNS program as the natural continuation of this very successful research program. Thus, we will take advantage of the existing administrative structure of the CCPDER to provide leadership to the CNS program with an emphasis on translational science. The CND will serve as the home for this research initiative. The majority of the investigators are housed within the CND and there is a well-developed series of seminars and data clubs that will foster collaboration in the Emory PD-CERC. The objectives of the Administrative Core are as follows: to lead the investigative team in collaborative research, to provide University-level input and expertise to the investigative team, to provide national-level expertise and oversight to the investigative team, and to foster development of technologies (therapeutics, predictive models, biomarkers) that may benefit the diagnosis, treatment, and outcome of Parkinson's disease patients. By pursuing these objectives, the administrative leadership will ensure that all project teams track toward our common goal for the CNS Program, which is to integrate clinical and basic research to identify and mitigate the adverse impact of environmental chemicals in Parkinson's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
5P01ES016731-03
Application #
8099778
Study Section
Special Emphasis Panel (ZES1)
Project Start
2010-07-01
Project End
2013-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
3
Fiscal Year
2010
Total Cost
$680,081
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Qi, Zhen; Voit, Eberhard O (2017) Inference of cancer mechanisms through computational systems analysis. Mol Biosyst 13:489-497
Lohr, Kelly M; Masoud, Shababa T; Salahpour, Ali et al. (2017) Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. Eur J Neurosci 45:20-33
Jones, Dean P (2016) Sequencing the exposome: A call to action. Toxicol Rep 3:29-45
Qi, Zhen; Yu, Gina P; Tretter, Felix et al. (2016) A heuristic model for working memory deficit in schizophrenia. Biochim Biophys Acta 1860:2696-705
Panuwet, Parinya; Hunter Jr, Ronald E; D'Souza, Priya E et al. (2016) Biological Matrix Effects in Quantitative Tandem Mass Spectrometry-Based Analytical Methods: Advancing Biomonitoring. Crit Rev Anal Chem 46:93-105
Kannarkat, G T; Cook, D A; Lee, J-K et al. (2015) Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study. NPJ Parkinsons Dis 1:
Bernstein, Alison I; Stout, Kristen A; Miller, Gary W (2014) The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int 73:89-97
Gao, Li; She, Hua; Li, Wenming et al. (2014) Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease. Antioxid Redox Signal 20:2936-48
Go, Young-Mi; Jones, Dean P (2014) Redox biology: interface of the exposome with the proteome, epigenome and genome. Redox Biol 2:358-60
Qi, Zhen; Miller, Gary W; Voit, Eberhard O (2014) Rotenone and paraquat perturb dopamine metabolism: A computational analysis of pesticide toxicity. Toxicology 315:92-101

Showing the most recent 10 out of 84 publications